A new study shows that sublingual immunotherapy against grass pollen allergy not only provides symptom relief during the period of administration, it also has long-lasting effects on symptom reduction 1 year after completing the course of treatment.
Presented December 9, 2009 at World Allergy Organization XXI World Allergy Congress (WAC), Buenos Aires, Argentina: Abstract 914.
http://www.medscape.com/viewarticle/713928
http://www.jacionline.org/article/S0091-6749(09)01583-8/abstract
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment